| Name | Title | Contact Details |
|---|
Nonpareil Corporation is one of the leading companies in the Manufacturing sector.
Based in Berkeley, CA, UPSIDE Foods (formerly known as Memphis Meats) is developing a way to grow real meat, poultry and seafood directly from animal cells, without the need to raise and slaughter animals. These products are not vegetarian, plant-based or meat alternatives -- they are real meat, made without the animal. Founded as the world`s first cultivated meat company in 2015, UPSIDE Foods has achieved numerous industry-defining milestones, including being the first company to produce multiple species of meat (beef, chicken and duck). The company believes that people shouldn`t have to choose between the foods they love and a thriving planet, and is working to build a better food system where everybody has access to delicious, humane, and sustainable meat. UPSIDE Foods has won various industry awards, including New York Times` Good Tech Awards, FastCo`s Next Big Thing in Tech, and the Best and Brightest Companies to Work For in the Nation by the National Association for Business Resources.
Neptune is a biotechnology company engaged primarily in the development and commercialization of marine-derived omega-3 polyunsaturated fatty acids ("PUFAs"). Neptune has a patented process of extracting oils from Antarctic krill, and principally sells omega-3 PUFAs as bulk oil to Neptune`s distributors who commercialize them under their private label primarily in the U.S., European and Australian nutraceutical markets. Neptune`s products generally come in bulk oil or capsule form and serve as a dietary supplement to consumers. Neptune`s head office is located at 545 Promenade du Centropolis, Suite 100, Laval, Quebec. Neptune respectively holds approximately 49% of the participating and voting rights of Acasti and 96% of the voting rights of NeuroBio. Through these subsidiaries, Neptune is also pursuing opportunities in the medical food and prescription drug markets. Acasti and NeuroBio respectively focus on the research and development of safe and therapeutically effective compounds for highly prevalent atherosclerotic conditions, such as cardiometabolic disorders and cardiovascular diseases, and for neurodegenerative and inflammation related conditions. Acasti`s lead prescription drug candidate is CaPre(R), a purified high omega-3 phospholipid concentrate derived from Neptune krill oil being developed to address the prevention and treatment of cardiometabolic disorders, including hypertriglyceridemia, which is characterized by abnormally high levels of triglycerides.
Clear Springs Foods Inc is one of the leading companies in the Manufacturing sector.